Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

28. September 2016 12:37 ET | Quelle: Commence Bio

Commence Bio to Present at 2016 Cell & Gene Meeting on the Mesa

SPARKS, MD--(Marketwired - September 28, 2016) - Commence Bio, Inc., a biotechnology company focused on developing breakthrough immunotherapies using its proprietary STaRT™ platform, announced today...
20. Juni 2016 18:45 ET | Quelle: Commence Bio

Commence Bio Receives 1st Patent for MSC1: A New Cancer Immunotherapy Platform

SPARKS, MD --(Marketwired - June 20, 2016) - Commence Bio, Inc. (Commence) today announced the issuance of a patent covering the company's STaRT 41™ technology utilized for producing MSC1 cells....
04. Januar 2016 14:54 ET | Quelle: Commence Bio

Commence Bio Finalizes Corporate Identity Change From WibiWorks Therapeutics and Introduces New Website

SPARKS, MD--(Marketwired - January 04, 2016) - Reflecting the STaRT™ of something big in immunotherapy, Commence Bio, Inc. today announced the completion of its corporate name change transition...
01. Oktober 2015 15:15 ET | Quelle: Commence Bio, Inc

Commence Bio to Present at 2015 Stem Cell Meeting on the Mesa

SPARKS, MD--(Marketwired - October 01, 2015) - Commence Bio, Inc., a biotechnology company focused on the development of MSC1 and MSC2 cellular immunotherapy platforms for cancer and inflammatory...